For: | Herszenyi L, Hritz I, Pregun I, Sipos F, Juhasz M, Molnar B, Tulassay Z. Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis. World J Gastroenterol 2007; 13(5): 676-682 [PMID: 17278189 DOI: 10.3748/wjg.v13.i5.676] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i5/676.htm |
Number | Citing Articles |
1 |
Martin Grimm, Maria Lazariotou, Stefan Kircher, Luisa Stuermer, Christoph Reiber, Andreas Höfelmayr, Stefan Gattenlöhner, Christoph Otto, Christoph T Germer, Burkhard HA von Rahden. MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status. Journal of Translational Medicine 2010; 8(1) doi: 10.1186/1479-5876-8-99
|
2 |
Polat Dura, Jody Salomon, Rene HM Te Morsche, Hennie MJ Roelofs, Jon O Kristinsson, Theo Wobbes, Ben JM Witteman, Adriaan CITL Tan, Joost PH Drenth, Wilbert HM Peters. No role for glutathione S-transferase genotypes in Caucasian esophageal squamous cell or adenocarcinoma etiology: an European case–control study. BMC Gastroenterology 2013; 13(1) doi: 10.1186/1471-230X-13-97
|
3 |
Tai Xu, Siming Zhang, Dongqin Qiu, Xiaoyuan Li, Yuanlin Fan. Association between matrix metalloproteinase 9 polymorphisms and breast cancer risk: An updated meta-analysis and trial sequential analysis. Gene 2020; 759: 144972 doi: 10.1016/j.gene.2020.144972
|
4 |
Zdenek Kala, Jiří Dolina, Filip Marek, Lydie Izakovicova Holla. Polymorphisms of glutathione S-transferase M1, T1 and P1 in patients with reflux esophagitis and Barrett’s esophagus. Journal of Human Genetics 2007; 52(6): 527 doi: 10.1007/s10038-007-0148-z
|
5 |
P. A. Bradbury, R. Zhai, J. Hopkins, M. H. Kulke, R. S. Heist, S. Singh, W. Zhou, C. Ma, W. Xu, K. Asomaning, M. Ter-Minassian, Z. Wang, L. Su, D. C. Christiani, G. Liu. Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis. Carcinogenesis 2009; 30(5): 793 doi: 10.1093/carcin/bgp065
|
6 |
Ksenia S. Maslyonkina, Alexandra K. Konyukova, Darya Y. Alexeeva, Mikhail Y. Sinelnikov, Liudmila M. Mikhaleva. Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression. Cancer Medicine 2022; 11(2): 447 doi: 10.1002/cam4.4447
|
7 |
Patricia González-Arriaga, Teresa Pascual, Arturo García-Alvarez, Ana Fernández-Somoano, M Felicitas López-Cima, Adonina Tardón. Genetic polymorphisms in MMP 2, 9 and 3genes modify lung cancer risk and survival. BMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-121
|
8 |
Gábor Lakatos, Ferenc Sipos, Pál Miheller, István Hritz, Mária Zsófia Varga, Márk Juhász, Béla Molnár, Zsolt Tulassay, László Herszényi. The Behavior of Matrix Metalloproteinase-9 in Lymphocytic Colitis, Collagenous Colitis and Ulcerative Colitis. Pathology & Oncology Research 2012; 18(1): 85 doi: 10.1007/s12253-011-9420-9
|
9 |
Weitao Hu, Taiyong Fang, Xiaoqing Chen. Identification of Differentially Expressed Genes and miRNAs for Ulcerative Colitis Using Bioinformatics Analysis. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.914384
|
10 |
Fu Yang, Jing Wen, Kongjia Luo, Jianhua Fu. Low GSTM3 expression is associated with poor disease‐free survival in resected esophageal squamous cell carcinoma. Diagnostic Pathology 2021; 16(1) doi: 10.1186/s13000-021-01069-4
|
11 |
Abdelbaset Buhmeida, Riyad Bendardaf, Marja Hilska, Yrjö Collan, Matti Laato, Stina Syrjänen, Kari Syrjänen, Seppo Pyrhönen. Prognostic Significance of Matrix Metalloproteinase-9 (MMP-9) in Stage II Colorectal Carcinoma. Journal of Gastrointestinal Cancer 2009; 40(3-4) doi: 10.1007/s12029-009-9091-x
|
12 |
Omnia Amir Abdelrazig, Fadilah Fadilah, Linda Erlina, Badriul Hegar. UNVEILING THERAPEUTIC TARGETS THROUGH PATHWAY ANALYSIS AND IDENTIFICATION OF DIFFERENTIALLY EXPRESSED GENES IN ULCERATIVE COLITIS. Ankara Universitesi Eczacilik Fakultesi Dergisi 2024; 48(3): 11 doi: 10.33483/jfpau.1439430
|
13 |
Zohar Pode, Ronny Peri-Naor, Joseph M. Georgeson, Tal Ilani, Vladimir Kiss, Tamar Unger, Barak Markus, Haim M. Barr, Leila Motiei, David Margulies. Protein recognition by a pattern-generating fluorescent molecular probe. Nature Nanotechnology 2017; 12(12): 1161 doi: 10.1038/nnano.2017.175
|
14 |
Winson Y. Cheung, Rihong Zhai, Penny Bradbury, Jessica Hopkins, Matthew H. Kulke, Rebecca S. Heist, Kofi Asomaning, Clement Ma, Wei Xu, Zhaoxi Wang, Suzanne Hooshmand, Li Su, David C. Christiani, Geoffrey Liu. Single nucleotide polymorphisms in the matrix metalloproteinase gene family and the frequency and duration of gastroesophageal reflux disease influence the risk of esophageal adenocarcinoma. International Journal of Cancer 2012; 131(11): 2478 doi: 10.1002/ijc.27541
|
15 |
László Herszényi, Gábor István, Romilda Cardin, Massimo De Paoli, Mario Plebani, Zsolt Tulassay, Fabio Farinati. Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers. European Journal of Cancer Prevention 2008; 17(5): 438 doi: 10.1097/CEJ.0b013e328305a130
|
16 |
David H. Wang, Rhonda F. Souza. Biology of Barrett's Esophagus and Esophageal Adenocarcinoma. Gastrointestinal Endoscopy Clinics of North America 2011; 21(1): 25 doi: 10.1016/j.giec.2010.09.011
|
17 |
Sima Ardalan Khales, Mohammad Reza Abbaszadegan, Ahmad Majd, Mohammad Mahdi Forghanifard. TWIST1 upregulates matrix metalloproteinase (MMP) genes family in esophageal squamous carcinoma cells. Gene Expression Patterns 2020; 37: 119127 doi: 10.1016/j.gep.2020.119127
|
18 |
Hui Ying Zhang, Stuart Jon Spechler, Rhonda F. Souza. Esophageal adenocarcinoma arising in Barrett esophagus. Cancer Letters 2009; 275(2): 170 doi: 10.1016/j.canlet.2008.07.006
|
19 |
Istvan Hritz, Hajnalka Gyorffy, Bela Molnar, Gabor Lakatos, Ferenc Sipos, Istvan Pregun, Mark Juhasz, Laszlo Pronai, Zsuzsa Schaff, Zsolt Tulassay, Laszlo Herszenyi. Increased p53 Expression in the Malignant Transformation of Barrett’s Esophagus is Accompanied by an Upward Shift of the Proliferative Compartment. Pathology & Oncology Research 2009; 15(2): 183 doi: 10.1007/s12253-008-9095-z
|
20 |
Adam Steg, Selwyn M. Vickers, Mohamad Eloubeidi, Wenquan Wang, Isam A. Eltoum, William E. Grizzle, M. Wasif Saif, Al F. Lobuglio, Andra R. Frost, Martin R. Johnson. Hedgehog Pathway Expression in Heterogeneous Pancreatic Adenocarcinoma: Implications for the Molecular Analysis of Clinically Available Biopsies. Diagnostic Molecular Pathology 2007; 16(4): 229 doi: 10.1097/PDM.0b013e31811edc7e
|
21 |
Lijuan Pang, Qiuxiang Li, Shugang Li, Jianwei He, Weiwei Cao, Jiaojiao Lan, Bin Sun, Hong Zou, Chengyan Wang, Ruixue Liu, Cuilei Wei, Yutao Wei, Yan Qi, Jianming Hu, Weihua Liang, Wen Jie Zhang, Mei Wan, Feng Li. Membrane type 1-matrix metalloproteinase induces epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: Observations from clinical and in vitro analyses. Scientific Reports 2016; 6(1) doi: 10.1038/srep22179
|
22 |
László Herszényi, Ferenc Sipos, Orsolya Galamb, Norbert Solymosi, István Hritz, Pál Miheller, Lajos Berczi, Béla Molnár, Zsolt Tulassay. Matrix Metalloproteinase-9 Expression in the Normal Mucosa–Adenoma–Dysplasia–Adenocarcinoma Sequence of the Colon. Pathology & Oncology Research 2008; 14(1): 31 doi: 10.1007/s12253-008-9004-5
|
23 |
Kathy Hormi-Carver, Rhonda F. Souza. Molecular Markers and Genetics in Cancer Development. Surgical Oncology Clinics of North America 2009; 18(3): 453 doi: 10.1016/j.soc.2009.03.002
|
24 |
László Herszényi, István Hritz, Gábor Lakatos, Mária Varga, Zsolt Tulassay. The Behavior of Matrix Metalloproteinases and Their Inhibitors in Colorectal Cancer. International Journal of Molecular Sciences 2012; 13(10): 13240 doi: 10.3390/ijms131013240
|
25 |
Hongyan Yao, Danli Xin, Zongyi Zhan, Zijing Li, Mohammad Abdollahi. Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/6642600
|
26 |
Katherine M. Weh, Yun Zhang, Connor L. Howard, Amy B. Howell, Jennifer L. Clarke, Laura A. Kresty. Cranberry Polyphenols in Esophageal Cancer Inhibition: New Insights. Nutrients 2022; 14(5): 969 doi: 10.3390/nu14050969
|
27 |
Akueni L. Davelaar, Daniëlle Straub, Navtej S. Buttar, Paul Fockens, Kausilia K. Krishnadath. Active matrix metalloproteases are expressed early on and are high during the Barrett’s esophagus malignancy sequence. Scandinavian Journal of Gastroenterology 2015; 50(3): 321 doi: 10.3109/00365521.2014.940379
|
28 |
Wen-Liang Fang, Wei-Bo Liang, Huan He, Yi Zhu, Shi-Liu Li, Lin-Bo Gao, Lin Zhang. Association of Matrix Metalloproteinases 1, 7, and 9 Gene Polymorphisms with Genetic Susceptibility to Colorectal Carcinoma in a Han Chinese Population. DNA and Cell Biology 2010; 29(11): 657 doi: 10.1089/dna.2010.1017
|
29 |
Ran Liu, Lihong Yin, Yuepu Pu, Yunhui Li, Geyu Liang, Juan Zhang, Xiaobo Li. Functional Alterations in the GlutathioneS-Transferase Family Associated with Enhanced Occurrence of Esophageal Carcinoma in China. Journal of Toxicology and Environmental Health, Part A 2010; 73(7): 471 doi: 10.1080/15287390903523394
|
30 |
Yin Li, Jun Ma, Qi Guo, Fangling Duan, Fu'ai Tang, Pengyuan Zheng, Zhiguo Zhao, Gaofeng Lu. Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. Diseases of the Esophagus 2009; 22(8): 664 doi: 10.1111/j.1442-2050.2008.00928.x
|
31 |
László Herszényi, Loránd Barabás, István Hritz, Gábor István, Zsolt Tulassay. Impact of proteolytic enzymes in colorectal cancer development and progression. World Journal of Gastroenterology 2014; 20(37): 13246-13257 doi: 10.3748/wjg.v20.i37.13246
|
32 |
Kristina Gopcevic, B. Rovcanin, D. Kekic, Z. Krivokapic, V. Dragutinovic. Matrix Metalloproteinase-2 and -9, Lactate, and Malate Dehydrogenase and Lipid Peroxides in Sera of Patients with Colorectal Carcinoma. Folia Biologica 2017; 63(5-6): 190 doi: 10.14712/fb2017063050190
|
33 |
László Herszényi, Fabio Farinati, Romilda Cardin, Gábor István, László D Molnár, István Hritz, Massimo De Paoli, Mario Plebani, Zsolt Tulassay. Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer. BMC Cancer 2008; 8(1) doi: 10.1186/1471-2407-8-194
|
34 |
Alok Kishorkumar Shah, Nicholas A. Saunders, Andrew P. Barbour, Michelle M. Hill. Early Diagnostic Biomarkers for Esophageal Adenocarcinoma—The Current State of Play. Cancer Epidemiology, Biomarkers & Prevention 2013; 22(7): 1185 doi: 10.1158/1055-9965.EPI-12-1415
|
35 |
Chun-Li Piao, Jin-Li Luo, De Jin, Cheng Tang, Li Wang, Feng-Mei Lian, Xiao-Lin Tong. Utilizing network pharmacology to explore the underlying mechanism of Radix Salviae in diabetic retinopathy. Chinese Medicine 2019; 14(1) doi: 10.1186/s13020-019-0280-7
|